MOUNTAIN VIEW, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at four investment conferences during the months of April and May 2013.
The conference presentation schedule is as follows:
| Needham 12th Annual Healthcare Conference |
| April 30, 2013, 1:40pm EDT |
| Westin Grand Central Hotel |
| New York, NY |
| Bank of America Merrill Lynch 2013 Health Care Conference |
| May 15, 2013, 4:20pm PDT |
| Encore at the Wynn |
| Las Vegas, NV |
| BioEquity Europe 2013 |
| May 23, 2013, 10:30am CEST |
| Sheraton Hotel |
| Stockholm, Sweden |
| Deutsche Bank 38th Annual dbAccess Health Care Conference |
| May 30, 2013, 3:30pm EDT |
| Westin Boston Waterfront Hotel |
| Boston, MA |
A live webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.
About VIVUS
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2012, and periodic reports filed with the Securities and Exchange Commission.